Please login to the form below

Not currently logged in
Email:
Password:

Wilmington Healthcare appoints managing director

Gareth Thomas joins the healthcare intelligence provider

Wilmington Healthcare Gareth ThomasUK-based Wilmington Healthcare has appointed Gareth Thomas as its managing director.

In his new role, Thomas will have responsibility for driving growth and integration in Wilmington Healthcare's four brands, Binley's, NHiS, OnMedica and Wellards.

Thomas moves to the healthcare intelligence provider from Informa, where he joined as European sales director in 2012 before promotion to his most recent role as director of global key accounts.

Previously, Thomas served as international development director for Doctors.net.uk - part of the M3 Group - and was responsible for setting up global physician online community alliance Networks in Health.

He also brings experience from pharmaceutical CRM and data provider Cegedim, where he was vice president for North Europe, and IMS Health, where he served as marketing director for global services.

Richard Adams, director of the Insight division at parent company Wilmington plc, said: “Gareth has a wealth of experience in sales and marketing for pharmaceutical and healthcare industries in the UK and overseas.

“We are delighted to welcome him to our company, where he will play a key role in helping us to realise our ambition to become a market leader in intelligence-led healthcare.”

25th July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics